Navigation Links
Valeant Pharmaceuticals Completes Acquisition of iNova
Date:12/22/2011

MISSISSAUGA, Ontario, Dec. 22, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced that effective December 21, 2011, the company completed its previously announced acquisition of iNova, from Archer Capital, Ironbridge and other minority management shareholders.

BofA Merrill Lynch and Baker & McKenzie acted as Valeant's advisors in connection with this transaction.

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com     


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Valeant to Acquire Polish Products
2. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
3. Valeant and Biovail Announce Results of Special Meetings of Shareholders
4. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
6. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
7. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
8. Valeant Announces Pricing of Senior Notes
9. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
10. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
11. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: ... the development and commercialization of targeted antiviral therapies, announced ... Annual ROTH Conference, to be held March 8-11, ... James Sapirstein , Chief Executive Officer, ... his live presentation and will be available to participate ...
(Date:3/5/2015)... Calif. , March 5, 2015  Asterias Biotherapeutics, ... the emerging field of regenerative medicine, announced today that ... the nation,s top rehabilitation hospitals for spinal cord injury ... 1/2a clinical trial of AST-OPC1 (oligodendrocyte progenitor cells) in ... spinal cord injury (SCI). The Phase ...
(Date:3/5/2015)... YORK and VANCOUVER, British Columbia ... (CSE: BUX FSE: 20B OTCQB: BMKDF) -- The ultimate ... an assay that is capable of detecting tumors before ... forty years, the development of such an assay has ... in academia and industry. Although many breakthrough diagnostics have ...
Breaking Medicine Technology:ContraVir to Present at 27th Annual ROTH Conference 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4New Cancer Diagnostic Primed to Change the Industry 2New Cancer Diagnostic Primed to Change the Industry 3New Cancer Diagnostic Primed to Change the Industry 4
... of Rosetta Genomics, microRNA-based,Test, miRview(TM) Squamous, Which Differentiates Squamous From non Squamous ... Diagnostic Methods, A Test Based on the miRview(TM) Technology First Approved for ... ... Earlier This Year, Rosetta Genomics is Expecting to Launch ...
... from the,French Medicine Agency (AFSSAPS) the authorization to ... PL37, its lead compound for oral,treatment of neuropathic ... pain condition, with an estimated,prevalence in the world,s ... most,recent surveys, with many causes such as shingles, ...
Cached Medicine Technology:Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I 2
(Date:3/5/2015)... (PRWEB) March 05, 2015 ... in healthcare communications and education, announced today its ... (AMP), the nation’s only medical conference designed for ... ischemia and lower limb amputation due to vascular ... family of innovative, evidence-based publications and CME activities ...
(Date:3/5/2015)... Califia Farms , the fastest-growing natural ... coffee drinks category[1], today unveils its new Concentrated Cold ... Calif. Concentrated Cold Brew (CCB) is the centerpiece ... the next wave of the coffee-taste evolution by giving ... their own baristas. , Califia Farms CCB has ...
(Date:3/5/2015)... March 05, 2015 Taking center ... Fort Worth, Texas April 9-11th is IDRevolution hosted ... providing personalized nutrition. IDLife offers a variety ... This customized approach to vitamin supplementation is ... with a free HIPAA compliant online assessment and ...
(Date:3/5/2015)... San Diego, CA (PRWEB) March 05, 2015 ... only the purest and most essential ingredients, the robust ... risk of allergic reactions. PASCHA Chocolate is free ... rice and sesame. Experience PASCHA's offering March 6th- 8th ... Smile! Chocolate Spread. PASCHA Chocolate has broken new ...
(Date:3/5/2015)... 2015 INTEGRATED Healthcare Strategies, a ... participate in its 2015 Children’s Hospitals Executive Compensation ... director-level positions, and the survey results are exclusive ... featured data on 60 executive and director level ... and 7 subsidiary children’s hospitals. Additionally, it provided ...
Breaking Medicine News(10 mins):Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4Health News:IDLife Partners John C. Maxwell and Troy Aikman speaking at IDRevolution in Fort Worth, TX April 9th-11th, 2015 2Health News:PASCHA Allergen Free Organic Chocolate to Appear at Natural Products Expo West March 6-8, 2015 2Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2
... commentary on the concerns of successive Australian governments, a ... the health of aborigines lags an appalling one century ... Torres Strait Islander people have significantly worse outcomes than ... ,In New Zealand, while inequality exists between Maori ...
... to improve patient care. In a recent report the use of ... US alone who succumb to sudden infant death syndrome each year. ... of Texas has come up with a new solution for sudden ... along with his friends developed a device that can warn a ...
... is causing confusion among scientists, //is the mystery of ... decipher the reason for this. Normal healthy adult bees abandon the ... ago it was seen that a mass exodus would leave the ... in the new phenomenon it is seen that new bees ...
... height of their football career is unparallel. This glamour and ... retires, and very soon replaced with depression. This is highlighted ... Health System. ,The chronic pain of the injuries ... often come to fore once they retire. This coupled with ...
... that antioxidant supplements interfere with the therapeutic effects ... //review of the use of antioxidants during chemotherapy. ... tumor response, and the patient’s ability to tolerate ... whose oncologists discourage the use of antioxidant supplements ...
... unusual scourge among the Mauritanian nomads - the force-feeding of ... ideal for brides-to-be. ,Mothers cross sticks around the ... girls cry out in pain. ,That is one ... of couscous for days on end until they developed wings ...
Cached Medicine News:Health News:Aborigines Century Behind the Health of Colonizers, WHO Report 2Health News:RFID Use can Avoid Sudden Infant Death Syndrome 2Health News:Vanishing Honey Bees 2Health News:Ex Pro-football Players Saddled With Depression After Retirement 2Health News:Antioxidants May Aid Chemotherapy Patients 2Health News:Force-feeding a Scourge Among Mauritanian Nomads 2Health News:Force-feeding a Scourge Among Mauritanian Nomads 3
The BacT/Alert 3D Select Link is a state of the art, automated microbial detection system that integrates blood, sterile body fluid and mycobacteria culturing. This system is useful when patient data...
The Vitek 2 - XL is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat ...
IDS Rapid Yeast Plus, a microbial identification system....
IDS Rapid One, a microbial identification system....
Medicine Products: